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Subsequent  to  the  action  of  complement,  discrete  ultrastructural  lesions 
have been observed on the surface of erythrocytes  and bacterial  cells.  These 
lesions have a  characteristic  shape and their  diameter varies  between 80 and 
103  A  depending on the source of complement used  (1,  2). Employing guinea 
pig serum as the source of complement, Borsos et al. (3) obtained results which 
suggested a correlation between the number of lesions observed electron micro- 
scopically and the number of functional lesions predicted by the one-hit theory 
of immune hemolysis (4). However, when human serum was used as the source 
of complement, many more lesions were observed than had been theoretically 
predicted (2). The present study was prompted by the resulting uncertainty as 
to whether  the  ultrastructural  phenomena  truly reflect functional  membrane 
lesions.  Its purpose is  (a)  to determine  the quantitative  relationship  between 
ultrastructural  lesions  and molecules  of complement proteins  present  on cells 
attacked by complement,  and (b)  to ascertain  at which stage during the com- 
plement reaction the lesions may first be visualized. 
Materials and Methods 
Purified Human Complement Components.--Each of the components of human complement 
were obtained  in purified form according to standard  procedures: C1 (5), C2 (6), C3 (7, 8), 
C4 (9), C5 (8), C6 (10), C7,1 C8 (11), and C9 (12). C2 was used throughout the present study 
in its oxidized form  (°xyC2) (13). For some experiments C3 and C5 were labeled  with  125I 
using the chloramine T method  (14). In neither case was the hemolytic activity of the com- 
ponent impaired by the labeling procedure and the specific radioactivity  for C3 was approxi- 
mately 30,000 cpm//zg and for C5, 100,000 cpm/#g. 
Preparation of  Erythrocyte-Antibody-Complement Complexes.---Complexes consisting  of 
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sheep erythrocytes (E), 2 rabbit antibody to sheep erythrocytes (A), and human complement 
proteins were prepared as previously described (12,  13). 
Determination of the Average Number of Complement Molecules Per CelL--Specific cellular up- 
take of C2  (15),  C3  (16),  and C4  (5) was calculated from input using previously established 
factors. The input of C4 and C2 was adjusted in order to achieve a  1:1 ratio between cell- 
bound C4 and C2 (15), and of C3 was adjusted to achieve a 1:100 ratio between cell-bound C4,2 
complexes and C3  molecules. In some experiments, when 125IC3  was  used,  the number of 
molecules of C3 bound to the cell was determined directly. Throughout the present work, the 
number of C5 molecules bound per cell was determined utilizing 125IC5. 
Preparation of an Erythrocyte-Complement Complex (EC 5,6,7) in the Absence oJ A ntibody.-- 
The intermediate complex EC5,6,7 was prepared from unsensitized sheep cells by the action 
of fluid phase C4,2,3 on C5, C6, and C7, by the method previously described (17). 
Removal of Complement Protein from EA C1, 4 ,2 ,3 and EA C1, 4 ,2 ,3 ,5 Complexes.--Trypsin 
at  a  final concentration of 0.1%  was added  to  a  2 ml suspension of EAC1,4,2,125IC3  or 
EAC1,4,2,3,12~IC5  cells containing 5 X  l0  s cells per ml in veronal buffered saline, pH  7.3, 
containing Ca  ++ and Mg  ++. Following incubation at 37°C  for 15 min, the cells were washed 
three times in the same buffer and the radioactivity remaining on the cells was determined and 
compared with that of similar complexes which had been incubated with buffer alone. 
Preparation of Stroma for Electron Microscopy.--Sensitized  sheep erythrocytes to which had 
been added all nine components of complement, or whole serum, underwent  100% hemolysis. 
Intermediate complexes lacking some of the later-acting components  were lysed by the addi- 
tion of distilled water. The number of cells used for preparation of the stroma varied but was 
never less than 5 X  l0  s. The stroma was washed three times by alternate centrifugation and 
resuspension in phosphate buffer, pH 6.5,  0.01 M, and the final pellet was suspended in 2% 
sodium  silicotungstate to  a  dilution of  approximately  1:100 and immediately fixed by the 
addition of a couple of drops of 10% aqueous neutral formalin (18). One drop of this suspension 
was placed on a 200 mesh grid coated with collodion and carbon. 
Calculation of the Number  of Lesions Per Cell.--In each experimental situation electron 
micrographs of at least 10 different membrane fragments were examined. The number of lesions 
in a measured area of each cell fragment was determined and the mean calculated. From this 
figure the number of lesions per cell was computed assuming the area of the red cell to be 25.8 
sq/z (19). 
RESULTS 
Quantitative  Relationship  Between  Ultrastructural  Lesions  and  Complement 
Molecules on the Surface of Lysed Erythrocytes--Sheep erythrocytes were treated 
with purified human  complement proteins so that an average of 1250 C4,2 com- 
plexes became bound  per cell.  The  cell preparation  was  then  reacted with  C3 
and  divided into two portions  (A and B)  which were incubated  with different 
quantities  of C5.  After incubation  the number  of bound  C5  molecules per cell 
was 3640 in A  and 71,000 in B. The cells were then lysed by treatment  with an 
excess  of  C6-C9  and  analyzed by electron microscopy.  The  results,  which  are 
listed in Table I, show that the number  of ultrastructural  lesions corresponded 
closely  to  the  number  of  C4,2  molecules,  but  not  to  that  of  C5  molecules 
present on these cells. 
2 Abbreviations used in this  paper:  A,  rabbit antibody to sheep erythrocytes;  E,  sheep 
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In a similar experiment, C4,2 and C5 were quantitatively valied (Table II). 
When the number of C5 molecules was in excess of the number of C4,2 com- 
plexes,  the  ultrastructural  lesions  corresponded  quantitatively  to  the  C4,2 
complexes present (preparation C). However, when the number of C4,2  sites 
was in excess of the number of C5 molecules, the number of lesions corresponded 
to the latter (D, E, F). It is apparent, therefore, that the ultrastructural lesions 
induced by complement are related to the number both of C4,2 and C5 mole- 
cules bound to cells. There was no apparent  quantitative  correlation between 
TABLE I 
The Rdationship  Between the Number  of Ultrastructural Lesions and the Number  of 
Cdl-Bound  C5 Molecules When C4,2 Complexes are Limiting 
Cell preparation  No. of C4,2  No. of C5  No. of ultrastructural 
complexes per cell*  molecules per cell;  lesions per cell 
A  1250  3,640  1200 
B  1250  71,000  1500 
* Specific cellular uptake of C2  (15) and C4 (5) was calculated from input using previ- 
ously established factors. 
~; The number of bound C5 molecules  per cell was determined utilizing 125IC5. 
TABLE II 
The Number  o/ Ultrastructural Lesions Observed When the Numbers  o/ C4,2 Complexes and 
C5 Molecules are Varied 
Cell preparation  No, of C4,2  No. of C5  No. of ultrastructural 
complexes per cell  molecules  per cell  lesions per cell 
C  1,000  7940  900 
D  20,000  3060  1560 
E  50,000  2046  1240 
F  50,000  7810  3350 
cell-bound C3  molecules and ultrastructural  lesions, since in each experiment 
bound C3 molecules were in 100-fold excess of the C4,2 complexes. 
The Complement Reaction Step at which Ultraslructural Lesions Appear--The 
various intermediate complexes from EA to EAC1,4,2,3,5,6,7,8,9  were pre- 
pared sequentially from the same cell suspension and were examined by electron 
microscopy. As recorded in Table III and documented in Figs.  1 and  2,  the 
ultrastructural lesions first became visible subsequent to the action of C5 and 
were not increased by the addition of later components. The finding of a small 
number of lesions in the EAC1-3 complex was due to a slight contamination of 
C3 with C5. In later experiments utilizing C3 free of C5, no lesions were seen at 
the EAC1-3 stage of the reaction. 
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sensitized sheep  erythrocytes  together  with  C6  and C7  by the  action of fluid 
phase  C4,2,3.  The  resulting  intermediate  complex,  previously  defined  as 
EC5,6, 7  (17),  could be lysed by C8 and C9.  When these cells were examined 
prior to treatment with C8 and C9, typical ultrastructura] lesions were visible. 
TABLE  III 
Analysis of Various Erythrocyte-Complement Complexes for  Ultrastruclural Lesions 
No. of ultrastruc-  Intermediate complex  Treatment  tura] lesions  per cell 
EA  None  0 
EAC1,4  None  0 
EAC 1,4,2  None  0 
EAC1,4,2,3  None  150" 
EAC1,4,2,3,5  None  1705 
EAC1,4,2,3,5  C6,7,8,9:~  1590 
EAC1,4,2,3,5,6  None  1120 
EAC1,4,2,3,5,6  C7,8,9§  1340 
EAC1,4,2,3,5,6,7  None  1060 
EAC1,4,2,3,5,6,7  C8,9 rl  1105 
EAC1,4,2,3,5,6,7,8  None  1680 
EAC1,4,2,3,5,6,7,8  C9  1509 
* C3 was slightly contaminated with C5; when C3 was  free of C5 no lesions were seen on 
EAC1,4,2,3. 
:~ Lysis after 90 rain at 37°C was less than 100%. 
§ 100%  lysis occurred in approximately 30 rain at 37°C. 
I] 100% lysis occurred in 10 rain at 37°C. 
FIG. 1.  (a) EAC1-3 intermediate complex. (b) EAC1-5 intermediate complex. In both cases, 
stroma prepared by osmotic lysis with H~O. Solid bar represents 500 A.  X 276,000. Repre- 
sentative lesions in (b) are indicated by arrows. FIG. 2.  (a) Sheep red cell lysed with whole human complement.  (b) EAC 1-5 intermediate 
complex.  No later components of complement added.  Membrane prepared by osmotic lysis 
with H20.  (c) The same EAC1-5 complex as depicted in 1 b, except lysis was induced by the 
addition of C6-9. Solid bar in each case represents 500 A.  X  340,000.  Representative lesions 
are indicated by arrows. 
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Persistence  of Ultrastructural Lesions After Removal of C3 and C5 by Trypsin-- 
Treatment  of EAC1,4,2,3  and  EAC1,4,2,3,5  with  trypsin  resulted  in  re- 
moval of approximately 95 % of C3 and 100 % of C5, as detected by radioactive 
label introduced into both proteins (Table IV). Stroma prepared from trypsin- 
treated EAC1,4,2,3,5  was examined by electron microscopy and  compared 
with  stroma  prepared  from  the  buffer-treated  control  cells.  The  number  of 
ultrastructmal lesions in both preparations was virtually identical. In the tryp- 
sin-treated  preparation,  the lesions were more clearly visible than in the  un- 
treated preparation. 
Can C6-Deficient  Rabbit Serum Produce Complement-Dependent  Ultrastruc- 
rural Lesions?--Sheep red cells sensitized with rabbit antibody were incubated 
with normal rabbit serum and with serum from a C6-deficient rabbit. 100% of 
the cells incubated with the normal rabbit serum lysed within 10 rain at 37°C, 
TABLE IV 
Effect of Removal of Cell-Bound C3 and C5 by Trypsin on Number of Ultrastructural Lesions 
radioactivity  No. of 
Intelmediate complex  Treatment  remainin~g  ultrastructural 
on the cell  lesions  per cell 
EAC1,4,2,125IC3  Buffer  100  0 
EAC 1,4,2,12 sIC  3  Trypsin  4.6  0 
EAC 1,4,2,3,12~IC5  Buffer  i00  300 
EAC1,4,2,3,1~5IC5  Trypsin  0  320 
Number of C3 molecules per cell (untreated),  146,000; number of C5 molecules per cell 
(untreated), 590. Trypsin treatment: 0.1% solution, 37°C, 15 rain. 
whereas even after incubation for 90 rain, no lysis was obtained with the C6- 
deficient rabbit serum. The unlysed ceils which had been treated with C6 de- 
ficient serum were lysed with water and the stroma was compared with  that 
produced by lysis with normal rabbit serum.  Ultrastructural lesions were pres- 
ent in both preparations;  they were, however, fewer in number in  the  stroma 
prepared from cells incubated with  C6-deficient rabbit serum than in the  con- 
trol.  The difference can probably be  explained by the known  effect of C6  on 
C5 uptake.  Experiments are under way to test this hypothesis. 
DISCUSSION 
The first studies on the nature of membrane lesions produced by complement 
were performed with Krebs ascites tumor cells. Following exposure to antibody 
and complement, these cells exhibited cytoplasmic swelling, rapid loss of intra- 
cellular K +, amino acids, and ribonucleotides, and less rapid loss of protein and 
ribonucleic acid (20,  21). The authors explained these changes by assuming the 
production of functional holes in the cell membrane of sufficient size to permit 
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regulation was thought to lead to swelling of the cells, "stretching" of the initial 
lesions, and resulting egress of large molecules (22). 
The ultrastructural manifestation of the action of complement on red cells 
is the appearance of discrete membrane lesions which were originally described 
as "holes." Similar lesions were produced when lecithin-cholesterol mixtures 
were treated with saponin (23, 24) and were interpreted by the authols to con- 
sist of an inner area of saponin-cholesterol micelles surrounded by a circle of 
lecithin-cholesterol micelles. Red cells  lysed by saponin  (24,  25)  and by the 
polyene antibiotic filipin (26) exhibited similar lesions. More recently, studies 
of  the  effect of  complement  on  the  endotoxic polysaccharide of  Veillonella 
alcalescens (27) and on lipid-free and lipid-containing membranes (1) suggested 
that the lesions first described as holes produced in membranes of red ceils sub- 
sequent to the action of complement (19, 3) may in fact not be holes, but might 
well be micelles formed in the lipoprotein layer of the red cell membrane. 
In the present study it became apparent that, under the conditions employed, 
a  direct quantitative relationship exists between the number of bound C4,2 
complexes and C5 molecules and the number of ultrastructural lesions. When the 
number of C5 molecules bound to the cell were in excess of the number of C4,2 
complexes, the latter determined the number of lesions per ceil; on the other 
hand, when the number of C4,2 complexes were in excess of the number of C5 
molecules, the number of lesions was determined by the number of C5 molecules. 
These data suggested, therefore, a  spatial relationship of cell-bound C2,  C4 
and C5 molecules to the complement-dependent ultrastructural lesions. Further, 
in preliminary studies utilizing ferritin-conjugated antibody to C5, the ferritin 
marker was found to be primarily localized in the center of or adjacent to the 
ultrastructural lesions. 
It has previously been demonstrated that only I of 20 cell-bound C4 molecules 
registers as an "effective molecule" (5) in the sense of the one-hit theory of im- 
mune hemolysis (4). In contrast, the present data demonstrate that each bound 
C4 molecule is capable of initiating the production of an ultrastructural mem- 
brane lesion. Similarly, although 3-12 cell-bound C5 molecules are required to 
produce one effective molecule (28),  1 in 2 of these molecules is capable of evok- 
ing the  characteristic lesion.  Further,  the complexes EAC1-5,  EAC1-6,  and 
EAC1-7 (but not EAC1-3) possessed approximately the same number of ultra- 
structural lesions. However, the rates of lysis induced by the terminal comple- 
ment components differed markedly between these complexes. With EAC1-7, 
the rate of lysis was rapid and complete; with EAC1-5, lysis was slow and in- 
complete. The difference in lysis of such complexes is known to be due to the 
decay of C5 sites on EAC1-5 prior to the addition of C6 and C7 (28). It may be 
concluded, therefore, that the ultrastructural lesions are distinct from the func- 
tional lesions which are responsible for cell lysis. Whereas the functional lesions 
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C5. The ultrastructural lesions are caused by C5 irrespective of the mechanism 
of its activation. In classical immune hemolysis C5 is activated by cell-bound 
C4,2,3.  By the recently described nonimmune mechanism, it is activated by 
fluid-phase C4,2,3  and bound to cells lacking antibody, C1,  C2,  C4,  and C3. 
The data further indicate that the ultrastructural lesions are unaffected by the 
decay of the hemolytic activity of bound  C5,  a  process which,  nevertheless, 
markedly reduces the number of functional lesions. 
The question arises, is the ultrastructural lesion a membrane defect, or is it a 
manifestation of a characteristic assembly of complement molecules? Humph- 
re),,  Dourmashkin, and Payne (1) have shown that treatment with trypsin or 
acid pH in order "to remove antibody and/or C' components" did not remove 
the ultrastructural lesions. However, conditions of treatment were not given 
nor was evidence supplied for removal of an), complement proteins. It has been 
shown previously in this laboratory (30)  that up to 95 % of the cell-bound C3 
can be removed by trypsin treatment of the cell complex. In the present study, 
when 95 % of C3 and 100 % of C5 were removed from the corresponding red cell 
intermediates by trypsin treatment, it was found that, as in the experiments of 
Humphrey eta]. (1), the ultrastructural lesions were not removed; in fact, their 
appearance was clarified due to the removal of background negative-staining 
material. Thus it may be concluded that the ultrastructural manifestation of the 
complement reaction is truly a reflection of a membrane alteration and not due 
to an accumulation of exogenous protein on the surface of the red cell. 
The relevance of the ultrastructural lesion to the functional lesion in the red 
cell which results in cell lysis still remains to be explained. It is apparent that 
the ultrastructural lesion itself is inert in producing cell damage. However, the 
possibility ex'sts that it could be a preselected site for the action of C8. Whereas 
C8 may have the potential to interact at the site of each u]trastructural lesion, 
its interaction at only one site may be sufficient to damage the cell with the re- 
sultant defect in osmotic regulation leading to death of the cell and liberation of 
its macromolecules. 
SUMMARY 
A direct quantitativ_..2e relationship has been demonstrated between the num 
ber of cell bound  C4,2  complexes or C5 molecules and the number of ultra- 
structural lesions visualized on the cell membrane subsequent to immune hemo- 
lysis. When bound C4,2 complexes exceeded bound C5 molecules, the number 
of ultrastructural  lesions seen corresponded to the  number of C5  molecules. 
However, in the reverse situation, with bound C5 molecules in excess of bound 
C4,2 complexes, the latter determined the number of lesions. During the com- 
plement-reaction sequence, the lesions first became visible in the nonlytic inter- 
mediate complex EAC1,4,2,3,5  and their number was unaffected when lysis 
was induced by C6-C9. Since the lesions were also demonstrable on the inter- 
mediate complex ECS, 6,7, it is concluded that the protein C5 is responsible for 
their production. Once formed, the physical presence of the C5 molecule is no POLLEY~ M1JLLER-EBERIKARD~ AND  FELDMAN  61 
longer required for the manifestation of the lesions as indicated by persistence 
of lesigns  after  removal  of  C5  protein  by trypsin.  The  C5-dependent ultra- 
structural  phenomenon  has  therefore  been  interpreted  to  represent  a  true 
structural change of the membrane which, however, is not accompanied by a 
permeability defect. 
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